Moderna announces new vaccine trial for kids
The KidCOVE study will collect data on vaccine efficacy in young kids ages 6 months to 11 years old. Author: Liz Lewin (WGRZ) Updated: 11:23 PM EDT March 16, 2021
BUFFALO, N.Y. The wait for a pediatric vaccine may not be much longer.
On Tuesday, Moderna announced the start of a new trial that tests their COVID vaccine in young children ages 6 months to 11 years old. The goal of this new study, dubbed KidCOVE, is to test the efficacy of the vaccine in kids.
The study, which is also a collaboration with the National Institute of Health, will test the vaccine on nearly 7,000 kids.